Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Case Report
Agomelatine Augmenting Partial Stimulant Response in ADHD and Mitigating Stimulant-induced Insomnia and Anxiety
1Child/Adolescent Psychiatrist, Kuwait Centre for Mental Health (KCMH)
2General Adult Psychiatrist, Neuromodulation & Psych Rehab, KCMH
- *Corresponding Author:
- Ahmed Naguy
Department of Child and Adolescent Psychiatrist
Kuwait Centre for Mental Health (KCMH), Kuwait
Tel: +965/65541937
Email: ahmednagy@hotmail.co.uk
Received Date: April 22, 2015 Accepted Date: May 14, 2015 Published Date: May 21, 2015
Citation: Naguy A, Tajali AA (2015) Agomelatine Augmenting Partial Stimulant Response in ADHD and Mitigating Stimulant-induced Insomnia and Anxiety. J Child Adolesc Behav 3:208. doi:10.4172/2375-4494.1000208
Copyright: © 2015 Naguy A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Attention deficit hyperactivity disorder (ADHD) is amenable to successful pharmacologic treatment with stimulants being first-line. Stimulants are generally safe but could be associated with some adverse effects such as insomnia and anxiety exacerbation in this population, both of which could jeopardize treatment-adherence and blunt the therapeutic response. Here, we are reporting a 13-year-old case of severe ADHD with mediocre response to an adequate trial of methylphenidate with stimulant-related anxiety and insomnia that robustly showed marked cognitive improvement and amelioration of both anxiety and insomnia after augmentation with agomelatine with great safety and tolerability.
